Fumihito Hosoi

1.6k total citations
22 papers, 1.3k citations indexed

About

Fumihito Hosoi is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Fumihito Hosoi has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Oncology and 5 papers in Genetics. Recurrent topics in Fumihito Hosoi's work include Chronic Lymphocytic Leukemia Research (5 papers), HER2/EGFR in Cancer Research (4 papers) and Mechanisms of cancer metastasis (4 papers). Fumihito Hosoi is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), HER2/EGFR in Cancer Research (4 papers) and Mechanisms of cancer metastasis (4 papers). Fumihito Hosoi collaborates with scholars based in Japan, United States and Czechia. Fumihito Hosoi's co-authors include Mayumi Ono, Michihiko Kuwano, Yuji Basaki, Yoshinao Oda, Kosuke Watari, Kimitoshi Kohno, Hiroto Izumi, Abbas Fotovati, Masazumi Tsuneyoshi and Takashi Yao and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Cancer Research.

In The Last Decade

Fumihito Hosoi

21 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumihito Hosoi Japan 15 933 418 227 145 136 22 1.3k
Ceri Oldreive United Kingdom 15 1.2k 1.3× 626 1.5× 329 1.4× 197 1.4× 124 0.9× 26 1.8k
Leisl Packer Australia 16 815 0.9× 333 0.8× 163 0.7× 60 0.4× 112 0.8× 28 1.1k
Inge Tinhofer Austria 22 689 0.7× 427 1.0× 393 1.7× 183 1.3× 176 1.3× 50 1.4k
Meei‐Huey Jeng United States 19 1.2k 1.3× 565 1.4× 206 0.9× 91 0.6× 265 1.9× 30 1.9k
Julie A. Buckmeier United States 15 632 0.7× 339 0.8× 267 1.2× 275 1.9× 241 1.8× 20 1.3k
S. Sianna Castillo United States 13 1.0k 1.1× 327 0.8× 183 0.8× 134 0.9× 174 1.3× 14 1.4k
Mogens Winkel Madsen Denmark 20 565 0.6× 483 1.2× 146 0.6× 230 1.6× 192 1.4× 30 1.2k
Natascia Marino United States 19 744 0.8× 385 0.9× 119 0.5× 145 1.0× 277 2.0× 34 1.1k
Martin G. Dalin Sweden 12 778 0.8× 749 1.8× 371 1.6× 135 0.9× 361 2.7× 14 1.7k
Romina Marone Switzerland 16 1.1k 1.2× 267 0.6× 248 1.1× 100 0.7× 112 0.8× 24 1.5k

Countries citing papers authored by Fumihito Hosoi

Since Specialization
Citations

This map shows the geographic impact of Fumihito Hosoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumihito Hosoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumihito Hosoi more than expected).

Fields of papers citing papers by Fumihito Hosoi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumihito Hosoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumihito Hosoi. The network helps show where Fumihito Hosoi may publish in the future.

Co-authorship network of co-authors of Fumihito Hosoi

This figure shows the co-authorship network connecting the top 25 collaborators of Fumihito Hosoi. A scholar is included among the top collaborators of Fumihito Hosoi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumihito Hosoi. Fumihito Hosoi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hosoi, Fumihito, et al.. (2015). OP0075 TAS5315, A Novel Bruton's Tyrosine Kinase (BTK) Inhibitor, Demonstrates Potent Efficacy in Mouse Collagen-Induced Arthritis Model. Annals of the Rheumatic Diseases. 74. 97–97. 4 indexed citations
3.
Watari, Kosuke, Tomohiro Shibata, Akihiko Kawahara, et al.. (2011). The antitumor effect of a novel angiogenesis inhibitor (an octahydronaphthalene derivative) targeting both VEGF receptor and NF‐κB pathway. International Journal of Cancer. 131(2). 310–321. 25 indexed citations
4.
Murakami, Yûichi, Fumihito Hosoi, Hiroto Izumi, et al.. (2010). Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43-dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells. Biochemical and Biophysical Research Communications. 396(2). 376–381. 70 indexed citations
5.
Basaki, Yuji, Kenichi Taguchi, Hiroto Izumi, et al.. (2010). Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells. European Journal of Cancer. 46(5). 954–965. 72 indexed citations
6.
Hosoi, Fumihito, Hiroto Izumi, Akihiko Kawahara, et al.. (2009). N-myc Downstream Regulated Gene 1/Cap43 Suppresses Tumor Growth and Angiogenesis of Pancreatic Cancer through Attenuation of Inhibitor of κB Kinase β Expression. Cancer Research. 69(12). 4983–4991. 88 indexed citations
7.
Zenmyo, Michihisa, Koji Hiraoka, Nobuhiro Fukushima, et al.. (2009). Role of NDRG1/Cap43 in osteogenic differentiation. Bone. 44. S321–S321. 1 indexed citations
8.
Oda, Yoshinao, Kentaro Kuroiwa, Mayumi Ono, et al.. (2009). N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin. Human Pathology. 41(2). 214–222. 50 indexed citations
9.
Hiraoka, Koji, Michihisa Zenmyo, Kosuke Watari, et al.. (2008). Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages. Cancer Science. 99(8). 1595–1602. 105 indexed citations
10.
Watari, Kosuke, Shintaro Nakao, Abbas Fotovati, et al.. (2008). Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-κB activation. Biochemical and Biophysical Research Communications. 377(3). 826–831. 89 indexed citations
11.
Kimura, Yusuke, Kosuke Watari, Abbas Fotovati, et al.. (2007). Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis. Cancer Science. 98(12). 2009–2018. 108 indexed citations
12.
Oda, Yoshinao, Takashi Eguchi, Shin-ichi Aishima, et al.. (2007). Expression profile of class I histone deacetylases in human cancer tissues. Oncology Reports. 18(4). 769–74. 281 indexed citations
13.
Oie, Shinji, Mayumi Ono, Fumihito Hosoi, et al.. (2007). Alteration of dihydropyrimidine dehydrogenase expression by IFN-α affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cells. Molecular Cancer Therapeutics. 6(8). 2310–2318. 14 indexed citations
14.
15.
Aishima, Shinichi, Yuji Basaki, Yoshinao Oda, et al.. (2006). High expression of insulin‐like growth factor binding protein‐3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma. Cancer Science. 97(11). 1182–1190. 47 indexed citations
16.
Basaki, Y, Fumihito Hosoi, Yoshinao Oda, et al.. (2006). Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Oncogene. 26(19). 2736–2746. 128 indexed citations
17.
Inoue, Masayuki, Toyonobu Usuki, Nayoung Lee, et al.. (2006). Antitumor Enediyne Chromoprotein C-1027:  Mechanistic Investigation of the Chromophore-Mediated Self-Decomposition Pathway. Journal of the American Chemical Society. 128(24). 7896–7903. 18 indexed citations
18.
19.
20.
Tanaka, Toru, Hajime Nakamura, Akira Nishiyama, et al.. (2000). Redox regulation by thioredoxin superfamily; protection against oxidative stress and aging. Free Radical Research. 33(6). 851–855. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ceri Oldreive Breakdown of academic impact, for papers by Leisl Packer Breakdown of academic impact, for papers by Inge Tinhofer Breakdown of academic impact, for papers by Meei‐Huey Jeng Breakdown of academic impact, for papers by Julie A. Buckmeier Breakdown of academic impact, for papers by S. Sianna Castillo Breakdown of academic impact, for papers by Mogens Winkel Madsen Breakdown of academic impact, for papers by Natascia Marino Breakdown of academic impact, for papers by Martin G. Dalin Breakdown of academic impact, for papers by Romina Marone
Rankless by CCL
2026